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1 0BSummary 
 
This report presents the results of the sixth inter-laboratory comparison (ILC) organised by the European 
Union Reference Laboratory for Polycyclic Aromatic Hydrocarbons (EU-RL PAH) on the determination 
of the 15+1 EU priority PAHs in infant formula and solvent solution. It was conducted in accordance with 
ISO guide 43 and the IUPAC International Harmonized Protocol for the Proficiency Testing of Analytical 
Chemistry Laboratories. 
In agreement with National Reference Laboratories, the two test materials used in this exercise were 
commercial dry infant formula spiked with 15 + 1 EU priority PAHs and a solution in acetonitrile 
respectively toluene of the same set of PAHs. The materials were prepared gravimetrically and the analyte 
contents verified by isotope dilution gas chromatography mass spectrometry. 
Only officially nominated National Reference Laboratories of the EU Member States were admitted as 
participants.  
The participants were free to choose the method for the analysis of the materials. The performance of the 
participating laboratories in the determination of four PAHs (benz[a]anthracene, benzo[b]fluoranthene, 
benzo[a]pyrene, and chrysene) in infant formula was expressed by both z-scores and zeta-scores, which 
were calculated from the results reported by the participants. 
 
A summary of the performance of the participants in the determination of the four PAHs in the infant 
formula test material is given in the following table. 
Participants Reporting laboratories 
Calculated 
z-scores 
Calculated 
zeta-scores z-scores  2 z-scores  2
zeta-scores 
 2 
zeta-scores
 2 
# # # # # % # % 
25 24 96 88 83 86 58 66 
 
For the remaining 12 analytes, participants were asked to report only whether the analysis indicates that 
the analyte is above the LOD of their method (present) or not (absent). Upon the final value, false 
positives and negatives were assigned 1 point, which were counted up in the overall evaluation of the 
laboratory performance. Not reported results were awarded as well with one point. Hence the lower the 
number of points, the better was the performance of the laboratory. The following table contains the 
summary of the performance of the participants for the 12 remaining analytes. 
Participants Reporting laboratories 0 points 1 point 2 points 3 points 4 points >4 points 
# # # # # % # % 
25 23 14 7 0 0 1 2 
 
The percent deviation from the preparation concentration of the PAH solution in solvent was used to 
evaluate whether or not bias could have been caused by erroneous instrument calibration.  
However, in some cases bias was discovered. 
 
The main outcome of this study was that the vast majority of the NRLs performed satisfactorily in the 
determination of the four target PAHs in dry infant formula. Significant bias was identified only for a few 
laboratories. However, they are requested to perform thorough root cause analysis and corrective action. 
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2 1BIntroduction 
The Institute for Reference Materials and Measurements (IRMM) of the European Commission's Joint 
Research Centre hosts the European Union Reference Laboratory for Polycyclic Aromatic Hydrocarbons 
in Food (EU-RL-PAH). One of its core tasks is to organise inter-laboratory comparisons (ILCs) for the 
National Reference Laboratories (NRLs) [0F1, 1F2]. 
Polycyclic aromatic hydrocarbons (PAHs) constitute a large class of organic substances. The chemical 
structure of PAHs consists of two or more fused aromatic rings. PAHs may be formed during the 
incomplete combustion of organic compounds and can be found in the environment. In food, PAHs may 
be formed during processing and domestic food preparation, such as smoking, drying, roasting, baking, 
frying, or grilling.  
In 2002 the European Commission’s Scientific Committee on Food identified 15 individual PAHs as 
being of major concern for human health. These 15 EU priority PAHs should be monitored in food to 
enable long-term exposure assessments and to verify the validity of the use of the concentrations of 
benzo[a]pyrene (BaP) as a marker for a “total-PAH content” [2F3]. The toxicological importance of these 
compounds was confirmed in October 2005 by the International Agency for Research on Cancer (IARC), 
which classified BaP as carcinogen to human beings (IARC group 1), cyclopenta[cd]pyrene (CPP), 
dibenzo[a,h]anthracene, and dibenzo[a,l]pyrene as probably carcinogenic to human beings (group 2a), 
and nine other EU priority PAHs as possibly carcinogenic to human beings [3F4].  
As a consequence, the European Commission (EC) issued Commission Regulation (EC) No 1881/2006 
setting maximum levels of benzo[a]pyrene in food, Commission Regulation (EC) No 333/2007 laying 
down sampling methods and performance criteria for methods of analysis for the official control of 
benzo[a]pyrene levels in foodstuffs, and Commission Recommendation 2005/108/EC on the further 
investigation into the levels of PAHs in certain foods [4F5, 5F6, 6F7]. Additionally, the monitoring of 
benzo[c]fluorene (BcL), which corresponds to the "+1" on the EU priority PAH list, had been 
recommended in 2006 by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) [7F8]. 
In order to distinguish this set of PAHs from a set of PAHs that has been addressed by the US 
Environmental Protection Agency, known as the 16 EPA PAHs, the terminology 15+1 EU priority PAHs 
was chosen. They are listed in 167HTable 1.  
To evaluate the suitability of BaP as a marker for occurrence and toxicity of PAHs in food, the European 
Commission asked the European Food Safety Authority (EFSA) for a review of the previous risk 
assessment on PAHs carried by the Scientific Committee on Food (SCF).  
The scientific opinion on polycyclic aromatic hydrocarbons in food was published by EFSA's Panel on 
Contaminants in the Food Chain in June 2008 [8F9]. The Contaminants Panel concluded that 
benzo[a]pyrene on its own was not a suitable indicator for the occurrence of PAHs in food and that, based 
on the currently available data relating to occurrence and toxicity, four (PAH4) or eight substances 
(PAH8) were the most suitable indicators of PAHs in food, with PAH8 not providing much added value 
compared to PAH4. Following these conclusions, an approach for risk management was agreed in the 
Standing Committee on the Food Chain and Animal Health. It was agreed that maximum levels should be 
set for the four PAHs (PAH4) (benzo[a]pyrene, chrysene, benzo[a]anthracene and benzo[b]fluoranthene) 
A maximum level for the sum of the four PAHs respectively a subset thereof will be very likely 
introduced in legislation. In addition, maximum levels for benzo[a]pyrene will be maintained to ensure 
comparability of data. Nevertheless, analysis of all 15+1 EU PAHs in food was encouraged, which 
underpins the importance of this ILC. 
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Table 1: Names and structures of 15+1 EU priority PAHs  
1 5-Methy lchrysene (5MC) 
 
9 Cyclopenta[cd]pyrene (CPP) 
 
2 Benz[ a]anthracene (BaA) 
 
10 Dibenzo[a,e]pyrene (DeP) 
 
3 Benzo[ a]pyrene (BaP)  
 
11 Dibenz[a,h]anthracene  (DhA) 
 
4 Benzo[b]fluoranthene  (BbF) 
 
12 Dibenzo[a,h]pyrene (DhP) 
 
5 Benzo[ ghi]perylene (BgP) 
 
13 Dibenzo[a,i]pyrene (DiP) 
 
6 Benzo[ j]fluoranthene (BjF) 
 
14 Dibenzo[a,l]pyrene (DlP) 
 
7 Benzo[k]fluoranthene (BkF) 
 
15 Indeno[1,2,3-cd]pyrene (IcP) 
 
8 Chrysene (CHR) 
 
+ 1 Benzo[c]fluorene (BcL) 
 
 
 
3 2BScope 
As specified in Regulation (EC) No 882/2004 on official controls performed to ensure the verification of 
compliance with food and feed law, animal health and animal welfare rules [168H2], one of the core duties of 
EU-RLs is organising inter-laboratory comparison tests (ILCs).  
This inter-laboratory comparison study aimed to evaluate the comparability of analysis results reported by 
National Reference Laboratories for the 15+1 EU priority PAHs in infant formula, and to assess the 
influence of standard preparation and instrument calibration on the performance of individual participants. 
Another aspect concerned the appropriateness of the reported measurement uncertainty, as this parameter 
is important in the compliance assessment of food with EU maximum levels. 
The ILC was designed and evaluated along the lines of ISO guide 43 and the International Harmonized 
Protocol for the Proficiency Testing of Analytical Chemistry Laboratories, further denoted as Harmonized 
Protocol [10 ,   11]. 
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4 3BParticipating Laboratories 
Only officially nominated National Reference Laboratories of the EU Member States were admitted as 
participants. 
 
Table 2: List of participants to the ILC round 
Institute  Country 
Österreichische Agentur für Gesundheit und Ernährungssicherheit, Kompetenzzentrum Cluster Chemie Austria 
Scientific Institute of Public Health Belgium 
SGL - State General Laboratory, Environmental and other Food Contamination Laboratory Cyprus 
Nàrodní referenční laboratoř pro polycyklické aromatické uhlovodíky - Státní veterinární ústav Praha Czech Republic 
Division of Food Chemistry, National Food Institute, Technical University of Denmark Denmark 
Danish Plant Directorate, Laboratory for Feed and Fertilizers Denmark 
Tartu Laboratory of Health Protection Inspectorate  Estonia 
Finnish Food Safety Authority Evira Finland 
LABERCA, Laboratoire d'Etude des Résidus et des Contaminants dans les Aliments  France 
BVL - Bundesamt für Verbraucherschutz und Lebensmittelsicherheit Germany 
General Chemical State Laboratory (GCSL) Food Division - Laboratory Greece 
Central Agricultural Office, Food & Feed Safety Directorate, Food Residues Toxicological Dept.  Hungary 
Central Agricultural Office, Food and Feed Safety Directorate, Feed Investigation NRL  Hungary 
Public Analyst Laboratory Ireland 
Institute of Food Safety, Animal Health and Environment BIOR Latvia 
National Veterinary Laboratory (National Food and Veterinary Risk Assessment Institute) Lithuania 
Laboratory of the Food and Consumer Product Safety Authority  The Netherlands 
RIKILT- Institute of Food Safety The Netherlands 
Laboratory of Department of Food and Consumer Articles Research - National Institute of Hygiene Poland 
INETI Portugal 
State Veterinary and Food Institute Dolný Kubín (SVPUDK) Slovak Republic 
Institute of Public Health Maribor, Institute of Environmental Protection  Slovenia 
Centro Nacional de Alimentación - AESAN.  Spain 
Livsmedelsverket (SLV)  Sweden 
The Food and Environment Research Agency United Kingdom 
 
 
5 4BTime frame 
The ILC was agreed with the NRLs at the EU-RL-PAH workshop in Geel on 09 – 10 March 2010. It was 
announced on the IRMM web page and invitation letters were sent to the laboratories on 16 April 2010. 
Test samples were dispatched on 11 May 2010 and the deadline for reporting of results was 11 June 2010. 
The documents sent to the participants are presented in Annex 7. 
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6 5BTest materials 
6.1 18BPreparation and verification 
 
The test materials of this PT round were: 
1. Infant formula spiked with 15+1 EU priority PAHs, in the following denoted as IF. This matrix is 
mimicking the food category "Infant formulae and follow-on formulae, including infant milk and 
follow-on milk " specified in Commission Regulation (EC) No 1881/2006, which defines a 
maximum level for BaP of 1,0 µg/kg 
2. A solution of the 15+1 EU Priority PAHs in either acetonitrile (in the following denoted as: ACN) 
or toluene (in the following denoted as TOL) with undisclosed concentrations, which served for 
checking instrument calibration. 
 
In addition an aliquot of the infant formula material, which was used for the preparation of the spiked 
infant formula test material and a standard solution of PAHs with disclosed analyte content, depending of 
the preference of the particular participant, in either acetonitrile or toluene, were supplied to the 
participants. 
 
The test materials for the ILC were prepared at the EU-RL PAHs laboratories from neat certified 
reference materials (purchased from BCR®, Institute for Reference Materials and Measurements, Geel, 
Belgium) except cyclopenta[cd]pyrene (purchased from Biochemisches Institut für Umweltkarzinogene, 
Großhansdorf, Germany, benzo[c]fluorene (purchased from Dr. Ehrenstorfer, Germany), and 
dibenzo[a,i]pyrene (purchased from Campro Scientific, Germany). Single standard stock solutions of each 
analyte were produced by substitution weighing of neat substance on a microbalance and dissolution in 
toluene. These standard stock solutions were diluted further gravimetrically with acetonitrile respectively 
toluene to the final concentration.  
 
The infant formula material was prepared in several steps. At first commercial dry infant formula from 
three suppliers was mixed, homogenised, and checked by GC-MS analysis for presence of the target 
PAHs. Their content was found with the exception of BbF and CHR in all cases below 0,2 µg/kg. Then a 
portion of about 100 g of the bulk material was spiked in a slurry with acetonitrile with a subset of the 
target analytes. The acetonitrile was evaporated, and the dry, spiked infant formula material was mixed 
into 3400 g of the bulk infant formula.  
The analyte content of the test material IF was determined where applicable by isotope dilution GC-MS 
applying bracketing calibration against the certified reference material (CRM) SRM 2260a (National 
Institute of Standards and Technology, Gaithersburg, MD, USA). These measurement results were 
applied as assigned values for the proficiency assessment. The assigned values of the four PAHs that had 
to be quantified are listed in Table 3. For the other PAHs it is only indicated whether or not they were 
present in the test sample at a level above 0,2 µg/kg. 
About 70 sachets of IF material were produced and were stored at a temperature below 10 ºC. The amount 
of material in each sachet was about 50 g. 
 
The concentrations of the PAH solutions in solvent were verified where applicable against SRM 2260a. 
Isotope dilution gas chromatography mass spectrometry and bracketing calibration was used for that 
purpose. Statistical significant differences of the analyte concentration to the preparation concentrations 
were not found for any of the 15+1 EU priority PAHs which are contained in the CRM. The uncertainties 
of the standard preparations were determined from the individual uncertainty contributions of the purity of 
the applied CRMs and all handling steps applying the law of error propagation. The concentrations of the 
standard solutions are given in Table 4. About 100 ampoules of a volume of 5 mL containing each about 4 
mL of test material were filled for each standard solution under inert atmosphere and flame sealed. The 
ampoules were stored at a temperature below 10 ºC until dispatch. 
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Table 3: Analyte contents of the infant formula test material 
 
 Infant formula (IF) 
Analyte Content
# 
[µg/kg] 
P * 
[µg/kg] u
#
5MC Present## (≥0,2 µg/kg) 
BaA 2,1 0,4 0,08 
BaP 0,9 0,2 0,05 
BbF 4,0 0,8 0,12 
BcL Present## (≥0,2 µg/kg) 
BgP Absent## (<0,2 µg/kg) 
BjF Present## (≥0,2 µg/kg) 
BkF Present## (≥0,2 µg/kg) 
CHR 1,3 0,3 0,05 
CPP Present## (≥0,2 µg/kg) 
DeP Present## (≥0,2 µg/kg) 
DhA Present## (≥0,2 µg/kg) 
DhP Present## (≥0,2 µg/kg) 
DiP Present## (≥0,2 µg/kg) 
DlP Absent## (<0,2 µg/kg) 
ICP Present## (≥0,2 µg/kg) 
 verified by bracketing calibration against NIST SRM 2260a 
 gravimetrical preparation concentration of the material 
p*  standard deviation for proficiency assessment 
u combined standard uncertainty of the assigned value (applied for zeta-score calculation) 
 
Participants were asked to select the solvent most compatible with their analysis method. 
Each participant received at least one ampoule of the solution of the 15+1 EU priority PAHs in the chosen 
solvent with disclosed content and one ampoule of the solution of the 15+1 EU priority PAHs in the 
chosen solvent with undisclosed concentration. The earlier solution allowed the participants to check their 
instrument calibration against an external reference, whereas the latter allowed the organisers to evaluate 
whether or not instrument calibration could have caused bias. 
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Table 4: Analyte contents of the SOL test materials for this PT round 
 
 Toluene (SOL-TOL) 
Acetonitrile 
(SOL-ACN) 
Analyte Conc.## [µg/l] U conc.
## 
[µg/l] Conc.
## [µg/l] U conc.
## 
[µg/l] 
5MC 45,8 0,2 15,8 0,1 
BaA 37,1 0,2 54,8 0,2 
BaP 11,3 0,1 11,1 0,1 
BbF 41,5 0,2 102,6 0,5 
BcL 22,6 0,1 89,6 0,3 
BgP 24,1 0,1 47,5 0,3 
BjF 21,5 0,1 21,1 0,1 
BkF 114,7 0,5 67,7 0,3 
CHR 10,3 0,1 17,2 0,1 
CPP 13,1 0,1 21,6 0,2 
DeP 63,4 0,5 18,6 0,1 
DhA 49,0 0,5 20,6 0,2 
DhP 100,7 0,9 38,3 0,3 
DiP 22,2 0,5 54,8 1,3 
DlP 33,7 0,2 11,0 0,1 
ICP 81,8 0,5 90,6 0,6 
 obtained from gravimetrical preparation of the material 
 
6.2 19BHomogeneity and stability 
Homogeneity of the infant formula test sample was tested according to ISO standard 13528. Ten packages 
of the test samples were selected randomly and analysed by isotope dilution GC-MS applying bracketing 
calibration. The test material was rated sufficiently homogeneous and no trend was observed. Details of 
the homogeneity tests are given in Annex 1. 
 
The stability of the test materials was evaluated applying an isochronous scheme. Two sets of test samples 
were stored starting from sample dispatch till the expiry of the reporting period either at recommended 
(20°C) or suboptimal (20°C to 30°C, fluctuating) storage conditions, and analysed after the expiry of the 
reporting deadline by isotope dilution GC-MS under repeatability conditions. Significant differences of 
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the analyte contents between the two sets were not found. Stability of the samples over the whole study 
period can be assumed. 
 
7 6BDesign of the proficiency test 
 
The design of the PT foresaw replicate analyses of the test samples (three each for IF and the PAH 
solution in solvent) and reporting of the individual results of replicate analyses for both sample types, and 
additionally a "final result" for IF. The final result had to be reported together with the accompanying 
expanded measurement uncertainty (with a coverage factor of 2). This final result was used for 
performance assessment. 
Besides analysis results participants were asked to report also details of the applied analysis method. 
 
 
8 7BEvaluation of the results 
 
8.1 20BGeneral 
The most important evaluation parameter was the performance of the laboratories in the determination of 
the four target PAHs (benz[a]anthracene, benzo[b]fluoranthene, benzo[a]pyrene, and chrysene) in the 
infant formula test material, which was expressed by z-scores and zeta-scores. Besides this, other aspects 
were studied too.  
 
The correct identification of the other PAHs that were added to the infant formula test material was 
evaluated. For this purpose the participants were requested to report the limits of detection (LOD) of their 
analysis method for the respective analytes. Based on this data it was checked whether or not the reported 
qualitative statement (present/absent) was correct. The performance was expressed by points that were 
awarded and summed up for both false positive and false negative results. 
 
The correctness of instrument calibration was checked by including a standard solution in solvent with 
undisclosed content in the sample set. Furthermore the influence of instrument calibration on the results 
for the infant formula sample was evaluated. 
 
Finally the compliance with legislation of method performance characteristics for the determination of 
BaP was evaluated. 
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21BEvaluation criteria 
 
In the 2008 EU-RL workshop it was already agreed to omit the attribution of scores for the results 
reported for PAH standard solutions in solvent. The reason is that such scores could be misleading if 
presented to third parties because they could be mistaken for scores related to the analysis of food 
samples, which would include sample preparation. Hence the results for the standard solutions in solvent 
were evaluated for their percentage deviation from the known concentration of the individual analyte 
only.  
 
z-Scores 
 
For the infant formula material, z-scores were calculated based on the "final values". Only the four PAHs 
for which quantitative results were requested were considered in the evaluation. Equation 1 presents the 
formula for calculation of z-scores. 
 
Equation 1 
 
P
assignedlab Xxz 
   
where z refers to the z-score, xlab to the reported “final value”, Xassigned to the assigned value, and σP to the standard deviation for 
proficiency testing. 
 
It is anticipated that amended legislation will specify for all four PAHs similar requirements with regard 
to method performance. 
Hence the standard deviation for proficiency testing σP was set for the four PAHs equal to the maximum 
tolerated standard measurement uncertainty Uf as defined for benzo[a]pyrene by Commission Regulation 
(EC) No 333/2007 [10F7 ]:  
 
Equation 2 Uf = 22 )C((LOD/2)   
where Uf relates to the maximum tolerated standard measurement uncertainty, LOD to the required limit of detection, α to a 
numeric factor depending on the concentration C as given in Commission Regulation (EC) No 333/2007. 
 
The application of 169HEquation 2 with the assigned value for benzo[a]pyrene of 0,9 μg/kg and the maximum 
tolerated value of LOD of 0,3 μg/kg results in a value for Uf of 0,23 μg/kg (26 %) for the test material IF. 
In analogy the maximum tolerated relative standard uncertainties were for benz[a]anthracene 19 %, 
benzo[b]fluoranthene 20 %, and chrysene 23 %. 
 
The performance of the laboratories was classified according to ISO Guide 43-1 [10] and the Harmonised 
Protocol [11] 
|z|  2 = satisfactory 
2<|z|  3 = questionable 
|z| > 3 = unsatisfactory 
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zeta-Scores 
 
In addition to z-scores zeta-scores were calculated. In contrast to z-scores zeta-scores describe the 
agreement of the reported result with the assigned value within the respective uncertainties. 
Unsatisfactorily large zeta scores might be caused by underestimated measurement uncertainties 
respectively large bias, or a combination of both. Zeta-Scores were calculated according to Equation 3. 
 
Equation 3: 
22
assignedlab
assignedlab
uu
Xx
zeta 
  
where zeta refers to the zeta-score, xlab to the reported “final value”, Xassigned to the assigned value, ulab to the measurement 
uncertainty reported by the laboratory, and uassigned to the uncertainty of the assigned value. 
 
The interpretation of zeta scores is identical to that of z-scores: 
 
|zeta|  2 = satisfactory 
2<|zeta|  3 = questionable 
|zeta| > 3 = unsatisfactory 
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8.2 22BEvaluation of results for the standard solution in acetonitrile and toluene 
 
The concentrations of the standard solution in solvent (either acetonitrile or toluene) were not disclosed to 
the participants. They served for verifying of instrument calibration, since this part of the analytical 
process has major influence on the trueness of the results. The data reported by the participants were 
evaluated with regard to the performance of both the individual participant and the whole network of 
NRLs.  
 
The deviation of the median (see Kernel density plots in Annex 2) of all values from the assigned value 
was for most analytes marginal and was in general within the uncertainty of the estimates.  
In addition a systematic error in the preparation of the standard solutions, e.g. dilution error, can be 
excluded since the gravimetric preparation concentration of the standard solutions were verified where 
applicable against SRM 2260a (NIST). 
 
Some analytes caused difficulties for the whole group of participants. This especially concerns five 
analytes, the four dibenzopyrenes and cyclopenta[cd]pyrene, for which the average of the reported results 
for more than half of the participants deviated by more than 10 % from the assigned value. This can be 
explained by the physicochemical properties of these substances that hamper either gas chromatographic 
analysis (dibenzopyrenes) or analysis by high performance liquid chromatography with fluorescence 
detection (cyclopenta[cd]pyrene). Figure 1 shows for each analyte the number of results deviating within 
certain ranges from the assigned value. The highest number of results deviating from the assigned value 
for less than 10% was reported for BaP. 
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Figure 1: Cumulative frequency of averages of results reported for a) SOL-ACN and b) SOL-TOL 
deviating from the assigned value for the particular analyte by more than 30%, more than 20%, or 
more than 10% of the assigned values respectively (total number of results was for a): 14; b): 12) 
 
At first glance, this evaluation suggests that methods of analysis need improvement for some PAHs. 
However, when looking to the performance of the individual participants, it becomes clear that the 
observed deviations from the assigned values are rather systematic than random (Figure 2). Hence it may 
be concluded that biased standard preparation or mistakes during handling of the standard solution (e.g. 
biased dilution) caused the deviations and not problems with the analysis methods itself. For example 
participant K023 reported for all analytes results with negative relative bias exceeding the level of 30 %. 
The results of some other participants show similar trends. An exception seems to be provided by the 
performance for benzo[j]fluoranthene and benzo[a]pyrene. At least two third of the laboratories applying 
GC-MS (Figure 1b) for the determination of the two analytes reported results deviating from the 
preparation concentration by more than 10 %. This could be explained in case of benzo[j]fluoranthene 
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with separation problems and consequently biased peak integration. However it is not clear why the 
content of benzo[a]pyrene was underestimated. 
Apparently the supply of a PAH standard solution with disclosed analyte content did not have big impact 
on the correctness of instrument calibration. 
 
Figure 2: Cumulative frequency of averages of results reported for a) SOL-ACN and b) SOL-TOL 
deviating from the assigned value for the particular participant by more than 30%, more than 20%, 
or more than 10% of the assigned values respectively  
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Details of the evaluation of the results are given in Annex 2.  
There the first figures show the results for the individual analytes reported by the participants for the three 
replicate measurements. In addition, the assigned (reference) value is depicted as red dotted line and the 
median of all results from participants as green dotted line. The black dotted lines represent a deviation of 
± 10 %, 20 %, and 30 % respectively from the assigned value.  
The blue box indicates the standard deviation of the three measurements with the blue horizontal line 
indicating the mean of the three results. 
The Kernel density plots show the distribution of the data: the median and the assigned value are depicted 
as a green and a blue line respectively. 
The figures are complemented by tables, containing all results reported by the participants. 
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8.3 Evaluation of results for the dry infant formula test sample 
 
8.3.1  z-Scores 
The participants were requested to report the results of replicate measurements and a "final result" for the 
four target analytes, which is the result they wish to be applied in the proficiency assessment. z-Scores 
were attributed only to these final results. The individual results of replicate analyses were not rated. 
 
The 25 participants in the study in total reported 96 results for the four target PAHs, which equals to 96 % 
of the maximum 100 possible. About 86 % of the reported results were rated as satisfactory. 
Figure 3 gives an overview of the performance indicators assigned to the respective results. The larger the 
triangles, the larger were the differences to the assigned values. Red triangles indicate z-scores outside the 
satisfactory range. Eight out of the nine non-satisfactory results were reported by two laboratories only. 
 
The numerical values of the calculated z-scores are compiled in Table 5. z-Scores with an absolute value 
of above 2 are given in bold font (for BaP in red bold font). The huge z-scores of laboratory L644 seemed 
to be caused by a reporting mistake, as the results of the replicate analyses were comparable to those of 
the other participants.  
 
Figure 3: Overview of performance of participants in the analysis of target analytes. The larger the 
triangle the greater was the deviation from the assigned value. Yellow and red triangles indicate 
questionable and non-satisfactory performance respectively. 
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Table 5: Compilation of z-scores calculated from the “final values" for test material IF.  
z-scores outside the satisfactory range (|z|  2) are indicated by bold /red-bold (for BaP) font. N.R. 
denotes analytes for which "final results" were not reported. 
Participant BaA BaP BbF CHR Participant BaA BaP BbF CHR 
 z-score z-score z-score z-score  z-score z-score z-score z-score 
S181 -0,02 -0,77 -0,40 0,17 K023 -2,81 -2,14 -2,90 -2,49 
H333 -0,33 -0,31 -0,13 -0,13 G982 -0,24 -0,43 -0,64 -0,16 
I021 0,20 -0,43 -0,03 0,17 B028 -0,33 -0,14 -0,32 0,98 
R867 -0,24 -0,56 -0,73 -0,45 K486 -0,11 -0,26 0,63 0,07 
H328 -0,11 -0,18 -0,36 0,00 W490 -0,72 -0,67 -0,70 -0,08 
F103 -0,69 -0,86 -1,50 -1,45 K252 0,18 -0,26 -0,60 -0,09 
D252 N.R. N.R. N.R. N.R. S637 -1,02 -0,48 -1,26 -1,62 
L218 4,00 3,40 3,39 3,41 R027 -3,57 -0,48 -0,82 -0,84 
B101 -0,29 -0,56 -0,35 -0,51 W640 -0,47 0,42 0,21 0,49 
H559 -0,91 0,42 -0,27 0,17 L644 88,45 184,58 49,43 137,86 
V015 -0,87 -0,65 -1,03 -0,81 G410 -1,05 -0,69 -1,17 -0,90 
T796 0,25 -0,05 0,09 0,85 P874 -0,53 -0,35 -0,14 0,07 
D638 0,41 -0,22 -0,05 0,07     
 
 
The results of the data evaluation for the individual analytes are given in Annex 4. 
For each analyte the first figure shows the individual analysis results of the three replicate determinations. 
In addition, the assigned value is shown as red dotted line. The medians of the results of the participants 
are indicated by a green dotted line. The black dotted lines represent deviations from the assigned value of 
± 1p, ± 2p, and ± 3p respectively.  
The blue boxes represent the expanded uncertainties as reported by participants for the "final results". 
 
The median of all replicate analysis results was for three of the four target analytes slightly lower, but 
considering the uncertainty of the estimates, in good agreement with the assigned value.  
 
The second figure shows Kernel density plots, which indicate the distribution of the data. The median of 
the results of the participants and the assigned value are depicted as a green and a blue cross respectively. 
The Kernel density plots indicated deviations from normal distribution, which can be reasoned by biased 
results reported by some labs.  
 
Notably the majority of laboratories was able to quantify correctly BaP even at the level of the LOQ as 
specified in legislation (0.9µg/kg).  
 
 
8.3.2 zeta-Scores (-score) 
As measurement uncertainty plays a crucial role in the decision process on compliance of goods with 
European food law, zeta-scores were calculated besides z-scores in order to evaluate whether or not the 
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measurement uncertainties reported by the participants were realistic. In contrary to z-scores, for which a 
constant value of tolerable variability of the analysis results (standard deviation for proficiency 
assessment) is applied for all participants, zeta-scores are based on the measurement uncertainty reported 
by the particular participant. Hence a zeta score below an absolute value of two indicates that the 
deviation of the reported value from the assigned value is smaller than the expanded combined 
measurement uncertainty of the reported and assigned value. However, the reported measurement 
uncertainty must not exceed the maximum tolerable uncertainty, as specified in Commission Regulation 
(EC) No 333/2007. This was confirmed before calculating zeta-scores. The respective zeta-scores are 
listed in Table 6. 
 
The interpretation of zeta-scores is similar to that of z-scores. 
 
Table 6: Compilation of zeta-scores calculated from the “final values" for test material IF.  
zeta-scores outside the satisfactory range (|z|  2) are indicated by bold/red-bold (for BaP) font; N.C. 
denotes analytes for which measurements uncertainties were not reported, therefore the zeta-score could 
not be calculated, N.R. denotes analytes for which "final results" were not reported. 
Participant BaA BaP BbF CHR Participant BaA BaP BbF CHR 
 -score -score -score -score  -score -score -score -score 
S181 -0,03 -1,49 -0,58 0,24 K023 -11,83 -5,74 -16,69 -8,97 
H333 -1,13 -1,09 -0,39 -0,43 G982 -0,50 -0,90 -0,86 -0,44 
I021 0,97 -0,90 -0,13 0,73 B028 -0,77 -0,55 -1,63 2,60 
R867 N.C. N.C. N.C. N.C. K486 -0,18 -0,68 1,15 0,17 
H328 -0,16 -0,44 -0,51 0,01 W490 -3,42 -2,40 -2,44 -0,34 
F103 -1,18 -0,79 -4,39 -1,76 K252 0,48 -0,55 -2,54 -0,26 
D252 N.R. N.R. N.R. N.R. S637 -2,77 -1,22 -4,17 -5,55 
L218 4,99 5,02 5,39 4,13 R027 -19,79 -2,00 -5,44 -4,48 
B101 -1,14 -2,19 -1,65 -3,20 W640 -1,23 1,36 0,74 1,36 
H559 -1,14 0,38 -0,48 0,20 L644 N.C. N.C. N.C. N.C. 
V015 -2,86 -1,91 -3,23 -3,54 G410 -4,82 -2,68 -6,00 -4,82 
T796 1,21 -0,19 0,45 3,36 P874 -1,37 -0,72 -0,32 0,18 
D638 0,76 -0,52 -0,11 0,15      
 
From Table 6 it becomes evident that some laboratories underestimated their measurement uncertainties. 
Hence they should reconsider the magnitude of their measurement uncertainty statement.  
 
Similar can be retrieved from Figure 4, which contains for BaP graphical comparison of z-scores and zeta-
scores for BaP.  
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Figure 4: Comparison of z-scores and zeta-scores for BaP.  
Data were not available in case of empty fields, respectively some data reported by the participants L218, 
K023, and L644 led to scores outside the presented scale. 
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8.3.3 Qualitative analysis 
The other 12 PAHs were only evaluated for presence/absence, taking into account the levels of LOD 
reported by the particular participant for the different analytes. This resulted in false negative (F.N.) 
statements when the laboratory was not able to identify the particular analyte, despite its spiking level was 
above the LOD reported by the laboratory. Opposite to this, results were classified as false positive (F.P.) 
if the participant reported the presence of the analyte despite its absence was confirmed by the EU-RL at a 
level which was below the LOD reported by the participating laboratory. Each false positive respectively 
false negative statement was awarded with one point, which were then summed up. A special, but 
expected case was provided by CPP, which was spiked into the sample to a level of 0.8 µg/kg. Due to its 
lack of fluorescence, this level of content was not determinable by laboratories applying HPLC- FLD for 
its determination, and was below the LOD of laboratories applying HPLC-UV for the detection of this 
compound. This data are indicated in Table 7 by "<LOD" 
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Table 7: Compilation of results for the 12 non-target PAHs for test material IF. 
P means present, A means absent. False negatives and positives are indicated as F.N. and F.P. respectively 
and in bold font. The last column reports the sum of points (1 for each false positive / negative). N.R. 
denotes analytes for which "final results" were not reported. * LOD not reported by participant 
 
Lab ID 5MC BcL BgP BjF BkF CPP DeP DhA DhP DiP DlP IcP Total score 
S181 P F.N. A P P P P P P P A P 1 
H333 P P A P P <LOD P P P P A P 0 
I021 P P A P P <LOD P P P P A P 0 
R867 P P A P P P P P P P A P 0 
H328 P P A P P P P P P P A P 0 
F103 P P A P P P P P P P A P 0 
D252 N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. 12 
L218 P P F.P. P P P P P P P A P 1 
B101 P P A P P F.N. P P P P A P 1 
H559 F.N.* P A P P P P P F.N.* F.N.* F.P.* P 4 
V015 P P <refLOD P P P P P P P A P 0 
T796 P P A P P P P P P P A P 0 
D638 P P A P P P P P P P A P 0 
K023 P P A P P P F.N. P P P <refLOD P 1 
G982 P P A P P P P P P P A P 0 
B028 P P <refLOD P P <LOD P P P P A P 0 
K486 P P F.P.* P P P P P P P A P 1 
W490 P P A P P P P P P P A P 0 
K252 P P F.P. N.R. P N.R. P P P P A N.R. 4 
S637 F.N. P A P P N.R. P P P P A P 2 
R027 P P A P P P P P P P A P 0 
W640 P P A P P P P P P P <refLOD P 0 
L644 N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. 12 
G410 P P A F.N. P <LOD P P P P A P 1 
P874 P P A P P P P P P P A P 0 
 
Laboratory D638 reported <LOQ values instead of present or absent. However, it was confirmed that it 
has to be read as absent. Apart from that laboratory D252 did not report any result for the infant formula 
sample, and laboratory L644 did not report results for the 12 non-target PAHs. 
Quantitative results reported for an analyte which was not added to the material, were not rated as false 
positive if they corresponded to concentrations lower than the LOD of the method applied for verification 
of the absence of the analyte in the raw infant formula material that was used for the preparation of the 
test sample. The respective data is indicated by <refLOD. 
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8.3.4 Relative performance 
The participants might want to know how they performed in the study in relation to the other participants 
with regard to precision and agreement with the assigned values. 
The figures in Annex 5 allow laboratories identifying whether these two parameter are in agreement with 
those of the majority of laboratories. They allow to deduce whither bias (closeness to the assigned value, 
plotted on the x-axis) or precision (the standard deviation for repeatability, plotted on the y-axis) was the 
major cause for underperformance. The assigned value is depicted by a vertical solid red line; laboratories 
are represented by blue dots (mean value of the replicates and the associated standard deviation of the 
replicates). The light blue area indicates the satisfactory performance range, which is defined by the 
assigned value 2P along the x-axis and by the average standard deviation for repeatability along the y-
axis. The latter was obtained by analysis-of-variance of the data set received for each analyte, multiplied 
by 1,5. 
 
For instance, participant L218, whose performance was rated for all four target analytes not satisfactorily, 
reported results of replicate determinations with relative standard deviations comparable to those of the 
majority of participants. Hence the problem seems to be related to bias. This could be caused by erroneous 
instrument calibration or wrong recovery estimates. 
On the other hand, participant H559 obtained for all analytes satisfactory z-scores, but repeatability was 
above the limit of satisfactory standard deviation for all four target analytes. 
Concerned participants should verify if their position outside the satisfactory performance area is caused 
by bias or precision problems.   
It would be very much appreciated if root cause analysis would be performed by the participants 
observing this bias effect and if the identified reason for the deviations would be reported to the EU-RL at 
the next workshop. 
 
8.4 24BEvaluation of the influence of calibration on results 
The influence of calibration on the results for the infant formula test sample was evaluated by comparing 
the relative deviations of the reported results for the unknown standard solution in acetonitrile, 
respectively toluene from the preparation values to the relative deviations from the assigned values of the 
results for the infant formula sample. This was done by means of Youden plots.  
 
As examples the evaluations for BaP are given in 171HFigure 4. The different solvent solutions are marked by 
different colours and symbols. The blue line indicates identical relative deviations for both samples.  
As can be seen data points accumulate along the diagonal. Hence laboratories with significant relative 
deviations from the assigned/preparation values are requested to check their calibration solutions.  
Remarkably all laboratories that chose for acetonitrile as solvent for the standard solutions underestimated 
the BaP content of the infant formula material. This issue cannot be attributed to calibration errors as the 
results for the standard solution were equally distributed around the preparation concentration. Hence an 
explanation might be the overestimation of recovery, which will lead after the correction for recovery to 
underestimated analyte contents. 
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Figure 4: Youden plot of the relative deviations from the assigned value / preparation concentration for 
BaP in the standard solutions in solvent and the infant formula test material.  
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8.5 Methods applied 
 
A short outline of the analysis methods applied by the participants is given in Annex 6. 
 
8.6. 26BEvaluation of compliance with legislation 
 
The data for BaP were evaluated for compliance with the provisions given in Commission Regulation 
(EC) No 333/2007. All data received were compliant with legislation. However three participants (R867, 
D252, and L644) did not report measurement uncertainties with their analysis results, which is required 
according to Commission Regulation (EC) No 333/2007. Therefore, these laboratories are hereby 
requested to adapt their reporting mode accordingly. 
 
9 8BFollow-up actions for underperforming laboratories 
The EU-RL will set up follow-up measures in due time for all participating laboratories that received z-
scores > 3 as well as for laboratories that did not report results for the four target PAHs as required by 
Regulation (EC) No 882/2004, and by the Protocol for management of underperformance in comparative 
testing and/or lack of collaboration of National Reference Laboratories (NRLs) with European Union 
reference laboratories (EU-RLs) activities. 
 
 
 
10 10BConclusions 
Twenty four out of 25 participants reported analysis results for the infant formula test material. The 
performance of most participants was good. In total about 88 % of the attributed z-scores were below an 
absolute value of two, varying between 83 % for BaA, and 92 % for BaP. Almost all of the z-scores 
exceeding this level were attributed to the results of three laboratories only, whereas the 
underperformance of one laboratory seemed to be caused by a reporting mistake. Another laboratory 
underperformed in the determination of the BaA content. 
However, in summary it can be stated that 20 laboratories performed satisfactorily in the determination of 
the future four target PAHs in infant formula.  
Ten out of the 300 qualitative results for the 12 non-target PAHs were rated either false negative or false 
positive. However two laboratories did not report any results for these analytes, and another laboratory did 
not report results for three analytes. Difficulties were mainly experienced with the non-fluorescent PAH 
CPP, for which the LOD of a number of participants was far above the analyte content of the test sample. 
The great majority of NRLs in this inter-laboratory comparison applied analytical methods which, with 
regard to performance characteristics, are compliant wit current EU legislation. 
Laboratories that underperformed in the determination of the four PAHs in infant formula are requested to 
perform root cause analysis and corrective action. The effectiveness of corrective action will be evaluated 
by the EU-RL PAHs in the course of 2011. 
 
11B 
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82B 
Annex 1: Homogeneity data for the 16 EU priority PAHs in test material 
infant formula 
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Annex 2: Data for the solution of the 15+1 EU priority PAHs in 
acetonitrile (SOL-ACN)  
 
For all the Figures representing distribution of individual results, the following references apply to the 
graphics: individual results of replicate measurements (▲) are sorted by the laboratory mean values. 
The blue boxes represent the standard deviation of the replicate measurements and the mean 
(horizontal blue line in the box). The horizontal solid lines indicate the laboratories mean (green), the 
assigned value (red), and the black dotted lines a ± 10 %, 20 %, and 30 % deviation thereof (black). 
 
 
For all Kernel density plots the distribution of reported results id depicted as a light blue curve, the 
robust mean (median) of the reported results as a vertical green line and its 95% confidence interval as 
a green horizontal line, the assigned value as a blue vertical line and its uncertainty (as  the combined 
standard uncertainty) as a blue horizontal line.  
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5-methylchrysene (5MC) 
 
Figure 5: Distribution of individual results of replicate measurements of 5MC in SOL-ACN The 
assigned value is 15,8 µg/l 
 
Figure 6: Kernel Density Plot 
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Table 8: Individual results of replicate measurements of 5MC in SOL-ACN in μg/l 
 
Participant Result 1 Result 2 Result 3 
S181 15,82 15,64 15,79 
H333 18,5 18,38 17,82 
I021 16 15,7 15,4 
F103 14,2 15,8 16,3 
B101 15,7 15,5 15,1 
T796 15,3 15,1 15 
D638 15,5 16 15,8 
B028 16,59 16,54 16,64 
K252 17,97 18,12 17,21 
S637 16,14 16,15 16,05 
R027 14,08 14,1 13,95 
G410 16,68 16,2 16,59 
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27B enz[a]anthracene (BaA) 
 
Figure 7: Distribution of individual results of replicate measurements of BaA in SOL-ACN. The 
assigned value is 54,8 µg/l 
 
 
Figure 8: Kernel Density Plot 
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Table 9: Individual results of replicate measurements of BaA in SOL-ACN in μg/l  
 
Participant Result 1 Result 2 Result 3 
S181 55,82 55,39 55,66 
H333 62,38 63,93 63,65 
I021 55,2 52,3 51,1 
F103 52,3 53 47,5 
B101 62,4 61,8 61,1 
T796 55,1 55,2 55,1 
D638 55,8 53,7 55,9 
B028 57,14 57,37 57,42 
K252 58,86 57,5 56,61 
S637 56,46 56,65 56,01 
R027 47,09 47,56 47,6 
G410 58,04 56,91 57,08 
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27B enzo[a]pyrene (BaP) 
 
Figure 9: Distribution of individual results of replicate measurements of BaP in SOL-ACN. The 
assigned value is 11,1 µg/l 
 
 
Figure 10: Kernel Density Plot 
 
 
 
Lab B101 is outside the 
concentration range  
(see Table 3 for data) 
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Table 10: Individual results of replicate measurements of BaP in SOL-ACN in μg/l 
 
Participant Result 1 Result 2 Result 3 
S181 11,22 11,09 11,16 
H333 11,14 11,22 11,16 
I021 10,8 10,7 10,7 
F103 7,8 7,1 7,6 
B101 111,8 110,8 109,9 
T796 10,7 10,7 10,8 
D638 11,9 11,7 11,3 
B028 11,54 11,59 11,61 
K252 10,96 12,1 11,45 
S637 11,92 11,78 11,6 
R027 9,86 10,02 9,91 
G410 11,59 11,37 11,26 
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27B enzo[b]fluoranthene (BbF) 
 
Figure 11: Distribution of individual results of replicate measurements of BbF in SOL-ACN. The 
assigned value is 102,6 µg/l 
 
 
Figure 12: Kernel Density Plot 
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Table 11: Individual results of replicate measurements of BbF in SOL-ACN in μg/l  
 
Participant Result 1 Result 2 Result 3 
S181 108,42 108,33 107,49 
H333 120,49 120,72 122,89 
I021 103,9 97,3 96,8 
F103 99,9 96,6 94,7 
B101 150,8 150,8 150,9 
T796 103,8 102,9 102 
D638 102 100 104 
B028 107,22 107,37 107,7 
K252 100,03 101,67 95,02 
S637 104,01 104,1 103,77 
R027 86,7 87,41 86,42 
G410 106,54 107,25 104,93 
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27B enzo[c]fluorene (BcL) 
 
Figure 13: Distribution of individual results of replicate measurements of BcL in SOL-ACN. The 
assigned value is 89,6 µg/l 
 
 
Figure 14: Kernel Density Plot 
 
 
 
Lab R027 is outside the 
concentration range 
 (see Table 5 for data) 
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Table 12: Individual results of replicate measurements of BcL in SOL-ACN in μg/l  
 
Participant Result 1 Result 2 Result 3 
S181 89,6 90,56 91,33 
H333 103,52 105,73 105,29 
I021 90,1 86,2 85,2 
F103 74 81,7 76 
B101 86,9 86,3 86,5 
T796 91,3 90,3 90,9 
D638 88,8 91,4 91,5 
B028 96,64 96,83 95,66 
K252 86,41 88,26 86,66 
S637 89,28 89,84 89,33 
R027 8,37 8,65 8,65 
G410 92,74 94,39 92,81 
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Benzo[ghi]perylene (BgP) 
 
Figure 15: Distribution of individual results of replicate measurements of BgP in SOL-ACN. The 
assigned value is 47,5 µg/l 
 
 
Figure 16: Kernel Density Plot 
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Table 13: Individual results of replicate measurements of BgP in SOL-ACN in μg/l (blank cells indicate 
missing data) 
 
Participant Result 1 Result 2 Result 3 
S181 46,77 46,74 46,86 
H333 54,21 55,45 54,3 
I021    
F103 41,8 38,3 38 
B101 46,9 46,1 45 
T796 47,1 48 46,6 
D638 47,2 49,3 49,7 
B028 48,18 48,75 48,28 
K252 45,28 51,72 45,88 
S637 51,78 51,1 50,28 
R027 44,06 47,24 47,43 
G410 49,54 49,6 48,46 
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27B enzo[j]fluoranthene (BjF) 
 
Figure 17: Distribution of individual results of replicate measurements of BjF in SOL-ACN. The 
assigned value is 21,1 µg/l 
 
 
Figure 18: Kernel Density Plot 
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Table 14: Individual results of replicate measurements of BjF in SOL-ACN in μg/l (blank cells indicate 
missing data) 
 
Participant Result 1 Result 2 Result 3 
S181 11,46 12,03 14,86 
H333 21,82 20,76 22,42 
I021 20,5 19,5 19,7 
F103 5,4 5,3 6,1 
B101 19,8 20,6 20,3 
T796 18,9 20,3 21,1 
D638 21,3 22,2 22,1 
B028 21,49 21,29 21,65 
K252    
S637 20,75 21,23 21,05 
R027 19,81 23,66 17,24 
G410 20,51 19,18 19,18 
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27B enzo[k]fluoranthene (BkF) 
 
Figure 19: Distribution of individual results of replicate measurements of BkF in SOL-ACN. The 
assigned value is 67,7 µg/l 
 
 
Figure 20: Kernel Density Plot 
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Table 15: Individual results of replicate measurements of BkF in SOL-ACN in μg/l  
 
Participant Result 1 Result 2 Result 3 
S181 68,2 67,71 68,12 
H333 79,62 79,94 79,19 
I021 67,2 64,8 63,9 
F103 56,8 58,3 59,4 
B101 65,8 66,1 65,8 
T796 67,8 67,7 67,2 
D638 68,3 69,7 69 
B028 69,81 70,08 69,9 
K252 62,34 66,2 62,59 
S637 68,62 68,75 68,64 
R027 58,08 58,21 57,58 
G410 69,84 70,46 69,02 
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27BChrysene (CHR) 
 
Figure 21: Distribution of individual results of replicate measurements of CHR in SOL-ACN. 
The assigned value is 17,2 µg/l 
 
 
Figure 22: Kernel Density Plot 
 
 
 
Lab B101 is outside the 
concentration range  
(see Table 9 for data) 
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Table 16: Individual results of replicate measurements of CHR in SOL-ACN in μg/l  
 
Participant Result 1 Result 2 Result 3 
S181 17,83 17,81 17,91 
H333 20,58 19,88 20,3 
I021 17,8 17,3 17 
F103 15,5 16,9 15,7 
B101 45,2 44,5 44,2 
T796 16,5 16,1 16,5 
D638 18,5 18,8 18,6 
B028 18,8 18,65 18,92 
K252 20,45 20,31 18,83 
S637 18,89 18,19 17,89 
R027 14,51 15,28 15,39 
G410 18,87 18,45 18,78 
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Cyclopenta[cd]pyrene (CPP) 
 
Figure 23: Distribution of individual results of replicate measurements of CPP in SOL-ACN. 
The assigned value is 21,6 µg/l 
 
 
 
Figure 24: Kernel Density Plot 
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Table 17: Individual results of replicate measurements of CPP in SOL-ACN in μg/l (blank cells indicate 
missing data) 
 
Participant Result 1 Result 2 Result 3 
S181 20,84 22,27 19,4 
H333 19,48 20,53 20,32 
I021 20,4 17,7 20,6 
F103 19,4 18 17,1 
B101 20,44 20,19 20,21 
T796 24 23,5 23,5 
D638 22 22,6 21,4 
B028 15,95 17,52 16,01 
K252    
S637    
R027 36,4 36,4 37,02 
G410 25,91 26,49 24,08 
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Dibenzo[a,e]pyrene (DeP) 
 
Figure 25: Distribution of individual results of replicate measurements of DeP in SOL-ACN. The 
assigned value is 18,6 µg/l 
 
 
 
Figure 26: Kernel Density Plot 
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Table 18: Individual results of replicate measurements of DeP in SOL-ACN in μg/l  
 
Participant Result 1 Result 2 Result 3 
S181 18,38 18,38 18,43 
H333 20,94 20,74 21,26 
I021 18,6 17,6 17,9 
F103 19,2 20,9 21 
B101 18,6 18,4 18,2 
T796 18,4 18,5 18,3 
D638 20,4 19 19,1 
B028 19,06 18,94 19,06 
K252 17,76 20,4 18,82 
S637 19,58 19,44 19,21 
R027 18,67 19,64 19,86 
G410 19,26 19,2 18,61 
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27BDibenz[a,h]anthracene (DhA) 
 
Figure 27: Distribution of individual results of replicate measurements of DhA in SOL-ACN. 
The assigned value is 20,6 µg/l 
 
 
Figure 28: Kernel Density Plot 
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Table 19: Individual results of replicate measurements of DhA in SOL-ACN in μg/l (blank cells indicate 
missing data) 
 
Participant Result 1 Result 2 Result 3 
S181 19,79 20,01 20,18 
H333 23,59 24,29 24,14 
I021    
F103 17,4 16,3 17,8 
B101 20 19,8 19,7 
T796 20,1 20,6 20 
D638 21,3 21,2 21,3 
B028 20,25 21,07 20,49 
K252 19,22 20,78 19,72 
S637 21,65 21,63 21,49 
R027 20,74 21,67 21,74 
G410 20,92 21,05 20,46 
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27BDibenzo[a,h]pyrene (DhP) 
 
Figure 29: Distribution of individual results of replicate measurements of DhP in SOL-ACN. The 
assigned value is 38,3 µg/l 
 
 
 
Figure 30: Kernel Density Plot 
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Table 20: Individual results of replicate measurements of DhP in SOL-ACN in μg/l  
 
Participant Result 1 Result 2 Result 3 
S181 34,31 34,14 34,29 
H333 46,38 47,47 47,6 
I021 36,1 31,5 31,1 
F103 33,5 34,5 35,3 
B101 36,6 36,1 36 
T796 40,7 39 38,4 
D638 50,1 49 49 
B028 40,95 41,4 40,9 
K252 16,96 21,28 19,22 
S637 40,19 39,52 40,02 
R027 43,67 46,5 47,86 
G410 39,84 39,67 38,69 
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27BDibenzo[a,i]pyrene (DiP) 
 
Figure 31: Distribution of individual results of replicate measurements of DiP in SOL-ACN. The 
assigned value is 54,8 µg/l 
 
 
 
Figure 32: Kernel Density Plot 
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Table 21: Individual results of replicate measurements of DiP in SOL-ACN in μg/l  
 
Participant Result 1 Result 2 Result 3 
S181 48,13 48,22 48,52 
H333 57,85 58,48 56,11 
I021 49 48,3 49 
F103 40 40,8 42,1 
B101 58,4 56,5 55,2 
T796 59,9 57,7 55,6 
D638 65,1 65,3 62,6 
B028 53,66 54,69 54,46 
K252 36,28 41,36 38,03 
S637 55,45 55,57 54,06 
R027 58,24 60,9 61,83 
G410 57,95 57,29 58,2 
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27BDibenzo[a,l]pyrene (DlP) 
 
Figure 33: Distribution of individual results of replicate measurements of DlP in SOL-ACN. The 
assigned value is 11,0 µg/l 
 
 
 
Figure 34: Kernel Density Plot 
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Table 22: Individual results of replicate measurements of DlP in SOL-ACN in μg/l  
 
Participant Result 1 Result 2 Result 3 
S181 8,84 8,49 10,03 
H333 10,81 10,95 10,86 
I021 10,5 10 10,1 
F103 8,3 8,4 8,3 
B101 11,1 10,8 10,7 
T796 10,4 9,6 10,4 
D638 10,3 10,6 10,6 
B028 10,85 10,94 11,04 
K252 12,2 12,49 12,54 
S637 11,23 11,2 11,01 
R027 9,64 9,63 9,59 
G410 10,68 10,47 10,65 
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Indeno[1,2,3-cd]pyrene (IcP) 
 
Figure 35: Distribution of individual results of replicate measurements of IcP in SOL-ACN. The 
assigned value is 90,6 µg/l 
 
 
Figure 36: Kernel Density Plot 
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Table 23: Individual results of replicate measurements of IcP in SOL-ACN in μg/l (blank cells indicate 
missing data) 
 
Participant Result 1 Result 2 Result 3 
S181 92,7 90,5 92,29 
H333 103,03 109,05 104,76 
I021 90,4 85,4 86,4 
F103 85,1 83,3 81 
B101 88,1 87,9 88,3 
T796 90,2 90,2 90,6 
D638 94 93,8 92,9 
B028 97,56 96,8 97,38 
K252    
S637 90,73 91,53 91,18 
R027 87,51 91,43 91,69 
G410 95,19 95,25 93,07 
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Annex 3: Data for the solution of the 15+1 EU priority PAHs in toluene 
(SOL-TOL)  
For all the Figures representing distribution of individual results, the following references apply to the 
graphics: individual results of replicate measurements (▲) are sorted by the laboratory mean values. 
The blue boxes represent the standard deviation of the replicate measurements and the mean 
(horizontal blue line in the box). The horizontal solid lines indicate the laboratories mean (green), the 
assigned value (red), and the black dotted lines a ± 10 %, 20 %, and 30 % deviation thereof (black). 
 
 
For all Kernel density plots the distribution of reported results id depicted as a light blue curve, the 
robust mean (median) of the reported results as a vertical green line and its 95% confidence interval as 
a green horizontal line, the assigned value as a blue vertical line and its uncertainty (as  the combined 
standard uncertainty) as a blue horizontal line.  
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5-methylchrysene (5MC) 
Figure 37: Distribution of individual results of replicate measurements of 5MC in SOL-TOL. 
The assigned value is 45,8 µg/l 
 
 
Figure 38: Kernel Density Plot 
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Table 24: Individual results of replicate measurements of 5MC in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 44,94 48,46 42,51
H328 47 45,1 45,1
D252 46,1 47,7 42,2
L218 45,5 45,4 48,1
H559 42 42,2 44,1
V015 44,27 44,82 46,79
D638 45,9 47,5 42,9
K023 26,93 26,33 26,41
G982 49,3 49,1 50,5
K486 57,38 56,48 51,37
W490 38,9 39 37,6
W640 50,2 51,6 52,1
L644 42,5 42,6 42,5
P874 42,6 42,4 42,4
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27B enz[a]anthracene (BaA) 
 
Figure 39: Distribution of individual results of replicate measurements of BaA in SOL-TOL. The 
assigned value is 37,1 µg/l 
 
 
Figure 40: Kernel Density Plot 
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Table 25: Individual results of replicate measurements of BaA in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 36,54 38,52 35,33
H328 38,3 40,1 37,2
D252 34,5 34,1 35,5
L218 36,2 36,2 38,3
H559 36,8 36 34,5
V015 36,77 37,7 37,68
D638 37,5 37,9 36,4
K023 20,85 21,02 20,89
G982 35 34,8 34,2
K486 30,31 29,85 31,75
W490 34,6 35 35,3
W640 35,7 36,5 37,1
L644 34,7 34,8 34,8
P874 30,8 30,6 31,2
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27B enzo[a]pyrene (BaP) 
 
Figure 41: Distribution of individual results of replicate measurements of BaP in SOL-TOL. The 
assigned value is 11,3 µg/l 
 
 
 
Figure 42: Kernel Density Plot 
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Table 26: Individual results of replicate measurements of BaP in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 10,68 11,28 10
H328 10,3 10,7 10,2
D252 9,75 9,85 10,3
L218 10,4 10,4 10,3
H559 15,1 13,8 13,4
V015 13 13,08 13,08
D638 11,3 12 11,5
K023 6,25 6,18 6,23
G982 10,1 10,4 10
K486 15,26 15,26 13,06
W490 9,4 9,4 9,7
W640 11,8 12 12
L644 10,1 10,1 10,1
P874 11 11 10,8
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27B enzo[b]fluoranthene (BbF) 
 
Figure 43: Distribution of individual results of replicate measurements of BbF in SOL-TOL. The 
assigned value is 41,5 µg/l 
 
 
Figure 44: Kernel Density Plot 
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Table 27: Individual results of replicate measurements of BbF in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 41,2 43 40,82
H328 42,6 41,8 41,2
D252 46,2 43 39,2
L218 41,9 38,5 40,9
H559 43,4 46 44,5
V015 42,01 41,53 41,76
D638 41,2 43,6 47,2
K023 23,41 24,66 24,23
G982 44,8 44 43,5
K486 32,48 29,71 27,13
W490 35,3 36 36,2
W640 44,1 45,9 44,2
L644 39,1 39,2 39,2
P874 37,4 37,8 37,4
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27B enzo[c]fluorene (BcL) 
 
Figure 45: Distribution of individual results of replicate measurements of BcL in SOL-TOL. The 
assigned value is 22,6 µg/l 
 
 
Figure 46: Kernel Density Plot 
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Table 28: Individual results of replicate measurements of BcL in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 21,84 22,64 19,49
H328 23,5 25,1 21,6
D252 23 22,7 24,4
L218 23,4 22,3 23,8
H559 21,6 21,8 22,3
V015 21,56 23,43 21,83
D638 21,3 22,6 21,4
K023 13,2 13,08 13,13
G982 18,3 18,9 18,9
K486 27,23 26,5 25,08
W490 21,7 22 21,9
W640 24,9 24,5 25,8
L644 21,4 21,3 21,2
P874 19,2 19,8 19,6
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27B enzo[ghi]perylene (BgP) 
 
Figure 47: Distribution of individual results of replicate measurements of BgP in SOL-TOL. The 
assigned value is 24,1 µg/l 
 
 
 
Figure 48: Kernel Density Plot 
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Table 29: Individual results of replicate measurements of BgP in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 23,94 23,98 22
H328 24,2 23,8 24,1
D252 25,9 24,1 20,8
L218 25,5 21,8 22,8
H559 22,9 24,4 23,4
V015 23,86 23,87 23,73
D638 23,2 24,2 22,9
K023 13,22 12,98 12,9
G982 20,8 20,4 20,4
K486 27,16 27,97 29,2
W490 19,1 20 20
W640 23,4 23,8 23,8
L644 22,3 22,4 22,3
P874 22,4 22,6 22,4
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27B enzo[j]fluoranthene (BjF) 
 
Figure 49: Distribution of individual results of replicate measurements of BjF in SOL-TOL. The 
assigned value is 21,5 µg/l 
 
 
Figure 50: Kernel Density Plot 
 
 
 
 
Lab D638 is outside the 
concentration range  
(see Table 23 for data) 
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Table 30: Individual results of replicate measurements of BjF in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 21,11 22,02 21,83
H328 22,5 23,5 24,2
D252 16,6 19,6 17
L218 27,6 27,5 35
H559 22,6 22,3 22,8
V015 20,85 20,74 20,49
D638 111 113 130
K023 11,88 12,06 11,97
G982 18,2 18,9 20,1
K486 37,56 47,38 40,39
W490 25,7 28,5 28,9
W640 29 33,4 22
L644 24 27 24
P874 14,2 15 14,4
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27B enzo[k]fluoranthene (BkF) 
 
Figure 51: Distribution of individual results of replicate measurements of BkF in SOL-TOL. The 
assigned value is 114,7 µg/l 
 
 
Figure 52: Kernel Density Plot 
 
 
 
Lab D638 is outside the 
concentration range 
 (see Table 24 for data) 
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Table 31: Individual results of replicate measurements of BkF in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 113,38 120,48 111,69
H328 116,6 116,3 116,5
D252 131 137 95,6
L218 117,5 113,3 122,4
H559 98,9 97,8 98,5
V015 112,63 113,61 112,22
D638 22,1 22,6 24,8
K023 63,34 62,72 62,88
G982 134,7 133,3 132,4
K486 123,37 109,76 108,45
W490 125,6 125,4 126
W640 141,2 151,2 143,9
L644 100,6 100,3 100,5
P874 110,6 110,4 110,4
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27BChrysene (CHR) 
 
Figure 53: Distribution of individual results of replicate measurements of CHR in SOL-TOL. The 
assigned value is 10,3 µg/l 
 
 
Figure 54: Kernel Density Plot 
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Table 32: Individual results of replicate measurements of CHR in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 8,7 8,08 9,21
H328 9,82 9,44 9,52
D252 9,27 9,09 9,8
L218 13,4 13,6 13,9
H559 11,7 12,4 13,6
V015 10,89 10,96 11,58
D638 10,7 10,5 10,4
K023 5,54 5,02 5,91
G982 9,9 9,6 10
K486 17,08 15,94 14,94
W490 9,8 9,9 9,8
W640 11,6 11,8 11,9
L644 9,6 9,5 9,5
P874 9,8 9,8 9,8
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27BCyclopenta[cd]pyrene (CPP) 
 
Figure 55: Distribution of individual results of replicate measurements of CPP in SOL-TOL. The 
assigned value is 13,1 µg/l 
 
 
Figure 56: Kernel Density Plot 
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Table 33: Individual results of replicate measurements of CPP in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 11,62 12,07 12,23
H328 13,9 13,8 12,1
D252 11,2 10,4 11,8
L218 12,2 11,6 13,4
H559 12,7 12,4 12,6
V015 13,07 12,97 12,66
D638 12,4 12,3 13
K023 8,08 7,81 7,91
G982 13,8 13,2 13,6
K486 17,59 15,24 14,96
W490 12,4 12,8 12,4
W640 12 12,4 13
L644 12,6 12,6 12,6
P874 15 16,4 15,4
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27BDibenzo[a,e]pyrene (DeP) 
 
Figure 57: Distribution of individual results of replicate measurements of DeP in SOL-TOL. The 
assigned value is 63,4 µg/l 
 
 
 
Figure 58: Kernel Density Plot 
 
 
 
Labs P874 and K023 were 
outside of the displayed 
concentration range (see Table 
27 for data) 
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Table 34: Individual results of replicate measurements of DeP in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 61,88 64,86 61,59
H328 62,3 65,2 60,3
D252 73,9 74,2 65,4
L218 66,2 59,7 64,6
H559 58,5 59,8 59,1
V015 60,21 60,75 62,12
D638 56,5 57 64,1
K023 18,81 18,95 19,17
G982 62,1 61,6 61,7
K486 81,68 72,98 65,46
W490 64,6 68,1 64,9
W640 66,5 71,6 66,1
L644 70,3 70,2 70,3
P874 <1,9 <1,9 <1,9
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27BDibenz[a,h]anthracene (DhA) 
 
Figure 59: Distribution of individual results of replicate measurements of DhA in SOL-TOL. 
The assigned value is 49,0 µg/l 
 
 
Figure 60: Kernel Density Plot 
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Table 35: Individual results of replicate measurements of DhA in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 47,4 50,28 48,76
H328 50,3 50,2 48,9
D252 50,2 51,2 59,8
L218 46 43,9 46,4
H559 44,4 46,6 43,4
V015 48,03 46,74 47,51
D638 79,5 76,3 81,9
K023 26,86 28,46 29,34
G982 44,6 44,4 44
K486 60,09 56,22 56,38
W490 40,6 43,2 41,2
W640 57,9 56,2 58,7
L644 47,6 47,6 47,7
P874 46,4 46,4 45,8
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27BDibenzo[a,h]pyrene (DhP) 
 
Figure 61: Distribution of individual results of replicate measurements of DhP in SOL-TOL. The 
assigned value is 100,7 µg/l 
 
 
Figure 62: Kernel Density Plot 
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Table 36: Individual results of replicate measurements of DhP in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 109,76 109,22 102,23
H328 103,8 107,1 94,4
D252 92,4 92,3 101
L218 90,6 87,7 87,6
H559 98,3 101,4 97,5
V015 100,13 101,09 100,42
D638 105 108 98,1
K023 36 38,6 37,26
G982 96,2 94,5 94,9
K486 134,39 139,35 118,77
W490 97,2 103,4 101,6
W640 126,7 122,2 127,3
L644 79,1 79,3 79,1
P874 101 101,4 101,2
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27BDibenzo[a,i]pyrene (DiP) 
 
Figure 63: Distribution of individual results of replicate measurements of DiP in SOL-TOL. The 
assigned value is 22,2 µg/l 
 
 
Figure 64: Kernel Density Plot 
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Table 37: Individual results of replicate measurements of DiP in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 20,22 21,42 20,94
H328 21,4 21,9 19,2
D252 19,2 19,9 23,8
L218 19,7 18,3 18,5
H559 21,7 23,8 21,1
V015 21,71 21,33 21,66
D638 21,4 20 22
K023 11,99 14,12 12,81
G982 20,2 19,6 19,5
K486 34,9 30,69 31,12
W490 20,4 19,9 21,1
W640 23,4 22,2 22,5
L644 16 15,9 15,9
P874 23,6 22,6 22,2
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27BDibenzo[a,l]pyrene (DlP) 
 
Figure 65: Distribution of individual results of replicate measurements of DlP in SOL-TOL. The 
assigned value is 33,7 µg/l 
 
 
Figure 66: Kernel Density Plot 
 
 
 
Lab K023 was outside 
of the  displayed 
concentration range 
(see Table 31 for data)
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Table 38: Individual results of replicate measurements of DlP in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 34,22 36,5 30,9
H328 35,2 37,5 34,9
D252 29,8 31,8 34,6
L218 35,7 31 33
H559 31,6 30,7 34,2
V015 32,17 32,15 31,95
D638 34,5 34,4 35,2
K023 57,17 73,67 59,43
G982 30,9 30,7 30,1
K486 40,99 38,22 36,72
W490 33,1 32,6 32,1
W640 32,8 35,5 32,3
L644 29 29,1 29,1
P874 33,2 29,4 30,4
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27BIndeno[1,2,3-cd]pyrene (IcP) 
 
Figure 67: Distribution of individual results of replicate measurements of IcP in SOL-TOL. The 
assigned value is 81,8 µg/l 
 
 
Figure 68: Kernel Density Plot 
 
 
 
 103
Table 39: Individual results of replicate measurements of IcP in SOL-TOL in μg/l  
 
Participant Result 1 Result 2 Result 3 
R867 80,48 86,96 81,92
H328 83,3 83,4 84,8
D252 94,5 91,2 74,9
L218 80,2 80,4 81,3
H559 65,5 67,5 65,8
V015 82,37 82,29 83,99
D638 51,4 48,5 51
K023 45,24 46,6 43,2
G982 81,3 81,5 80,9
K486 94,92 94,16 94,03
W490 74,4 79 74,6
W640 85,9 90 86,3
L644 72 72 72,2
P874 77 76,4 77
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Annex 4: Data from the determination of the four target PAHs in test 
sample Infant formula (IF-FIN and IF-REP) 
For all the Figures representing distribution of individual results, the following references apply to the 
graphics: individual results of replicate measurements (▲) are sorted by the laboratory mean values. 
The blue boxes represent the standard deviation of the replicate measurements and the mean 
(horizontal blue line in the box). The horizontal solid lines indicate the laboratories mean (green), the 
assigned value (red), and the black dotted lines a ± 1, 2, 3 times the target standard deviation thereof. 
 
 
For all Kernel density plots the distribution of reported results id depicted as a light blue curve, the 
robust mean (median) of the reported results as a vertical green line and its 95% confidence interval as 
a green horizontal line, the assigned value as a blue vertical line and its uncertainty ( combined 
standard uncertainty) as a blue horizontal line.  
 
The light green band represents the uncertainty of the assigned value (as  the combined standard 
uncertainty) as obtained from the bracketing (verification) procedure applied to assign the reference 
value of the analyte in the material. 
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Benz[a]anthracene (BaA) 
 
Figure 69: Distribution of individual results of replicate measurements of BaA in IF. The 
assigned value is 2,1 µg/kg 
 
 
Figure 70: Kernel Density Plot 
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Table 40: Individual results of replicate measurements of BaA in IF in μg/kg (blank cells indicate 
missing data) 
 
Participant Result 1 Result 2 Result 3 Final results 
Uncertainty 
(k = 2) 
S181 2,099 2,064 2,17 2,1 0,63 
H333 1,88 2,07 1,92 1,96 0,21 
I021 2,1 2,2 2,2 2,2 0,1 
R867 1,96 1,96 2,09 2  
H328 2,28 1,99 1,91 2,06 0,58 
F103 1,7 1,9 1,8 1,8 0,5 
D252      
L218 3,9 3,6 4,2 3,9 0,7 
B101 2,01 1,92 2 1,98 0,16 
H559 1,5 2 1,5 1,7 0,7 
V015 1,7 1,84 1,62 1,72 0,22 
T796 2,27 2,19 2,19 2,22 0,09 
D638 2,2 2,39 2,27 2,29 0,45 
K023 0,85 0,81 0,88 0,85 0,14 
G982 1,9 2 2 2 0,4 
B028 2,17 1,88 1,84 1,96 0,35 
K486 2,06 2,07 2,07 2,06 0,52 
W490 1,766 1,773 1,823 1,787 0,098 
K252 2,19 2,24 2,12 2,19 0,3 
S637 1,56 1,62 1,77 1,65 0,29 
R027 0,53 0,51 0,5 0,51 0,02 
W640 1,8 1,9 2 1,9 0,3 
L644 1,86 1,9 1,86 41,7  
G410 1,58 1,7 1,64 1,64 0,11 
P874 1,9 1,89 1,83 1,87 0,31 
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43B enzo[a]pyrene (BaP) 
 
Figure 71: Distribution of individual results of replicate measurements of BaP in IF. The 
assigned value is 0,9 µg/kg 
 
 
Figure 72: Kernel Density Plot 
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Table 41: Individual results of replicate measurements of BaP in IF in μg/kg (blank cells indicate 
missing data) 
 
Participant Result 1 Result 2 Result 3 Final results 
Uncertainty 
(k = 2) 
S181 0,755 0,655 0,759 0,72 0,22 
H333 0,75 0,92 0,81 0,83 0,08 
I021 0,7 0,9 0,9 0,8 0,2 
R867 0,74 0,78 0,92 0,77  
H328 0,91 0,87 0,8 0,86 0,16 
F103 0,6 0,6 0,7 0,7 0,5 
D252      
L218 1,6 1,7 1,7 1,7 0,3 
B101 0,78 0,75 0,77 0,77 0,06 
H559 1,3 1 0,7 1 0,5 
V015 0,72 0,81 0,7 0,75 0,12 
T796 0,92 0,88 0,85 0,89 0,07 
D638 0,81 0,89 0,84 0,85 0,17 
K023 0,39 0,4 0,42 0,4 0,14 
G982 0,9 0,8 0,8 0,8 0,2 
B028 0,9 0,87 0,84 0,87 0,05 
K486 0,83 0,81 0,89 0,84 0,15 
W490 0,729 0,733 0,773 0,745 0,078 
K252 0,85 0,88 0,78 0,84 0,2 
S637 0,78 0,8 0,79 0,79 0,15 
R027 0,77 0,79 0,8 0,79 0,04 
W640 1 0,9 1 1 0,1 
L644 1,02 1,01 1,03 44,2  
G410 0,72 0,78 0,72 0,74 0,06 
P874 0,83 0,83 0,8 0,82 0,2 
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43B enzo[b]fluoranthene (BbF) 
 
Figure 73: Distribution of individual results of replicate measurements of BbF in IF. The 
assigned value is 4,0 µg/kg 
 
 
Figure 74: Kernel Density Plot 
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Table 42: Individual results of replicate measurements of BbF in IF in μg/kg (blank cells indicate 
missing data) 
 
Participant Result 1 Result 2 Result 3 Final results 
Uncertainty 
(k = 2) 
S181 3,72 3,43 3,96 3,7 1,1 
H333 3,7 4,05 4,03 3,92 0,47 
I021 3,8 4,1 4 4 0,3 
R867 3,23 3,4 3,65 3,43  
H328 4,15 3,58 3,45 3,73 1,12 
F103 2,9 2,8 2,7 2,8 0,5 
D252      
L218 6,7 6,7 6,9 6,8 1 
B101 3,78 3,66 3,78 3,74 0,24 
H559 3,6 3,8 4 3,8 0,9 
V015 3,08 3,45 3,02 3,18 0,46 
T796 4,22 4,02 4,05 4,1 0,22 
D638 3,8 4,2 3,95 3,98 0,8 
K023 1,61 1,6 1,73 1,65 0,14 
G982 3,4 3,5 3,6 3,5 1,2 
B028 3,87 3,76 3,66 3,76 0,21 
K486 4,35 4,43 4,84 4,54 0,86 
W490 3,398 3,371 3,597 3,455 0,395 
K252 3,57 3,77 3,26 3,53 0,3 
S637 2,94 3,01 3,01 2,99 0,43 
R027 3,35 3,34 3,36 3,35 0,01 
W640 4,2 4 4,4 4,2 0,4 
L644 3,38 3,41 3,38 44,5  
G410 2,99 3,16 3,06 3,07 0,2 
P874 3,94 4,03 3,76 3,91 0,67 
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43BChrysene (CHR) 
 
Figure 75: Distribution of individual results of replicate measurements of CHR in IF. The 
assigned value is 1,3 µg/kg 
 
 
Figure 76: Kernel Density Plot 
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Table 43: Individual results of replicate measurements of CHR in IF in μg/kg (blank cells 
indicate missing data) 
 
Participant Result 1 Result 2 Result 3 Final results 
Uncertainty 
(k = 2) 
S181 1,41 1,31 1,46 1,4 0,42 
H333 1,46 1,34 1,11 1,31 0,15 
I021 1,4 1,3 1,4 1,4 0,1 
R867 1,14 1,27 1,21 1,21  
H328 1,48 1,31 1,26 1,35 0,35 
F103 0,9 0,9 1 0,9 0,5 
D252      
L218 2,5 2,5 2,4 2,4 0,5 
B101 1,19 1,16 1,22 1,19 0,01 
H559 1 1,1 2 1,4 0,5 
V015 1,08 1,17 1,06 1,1 0,1 
T796 1,67 1,61 1,55 1,61 0,12 
D638 1,31 1,45 1,36 1,37 0,27 
K023 0,57 0,57 0,61 0,58 0,14 
G982 1,3 1,3 1,4 1,3 0,2 
B028 1,73 1,69 1,53 1,65 0,21 
K486 1,35 1,35 1,43 1,37 0,23 
W490 1,311 1,295 1,364 1,323 0,116 
K252 1,35 1,32 1,3 1,32 0,2 
S637 0,86 0,84 0,85 0,85 0,15 
R027 1,12 1,06 1,08 1,09 0,06 
W640 1,5 1,5 1,6 1,5 0,2 
L644 1,2 1,21 1,23 43,9  
G410 1,03 1,11 1,08 1,07 0,06 
P874 1,4 1,39 1,32 1,37 0,22 
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Annex 5: Precision and closeness to assigned value in IF 
Figures are obtained from the results of replicate measurements for the infant formula (IF-REP). 
Therefore, the points associated with the laboratories are not necessarily related with the score 
attributed to each laboratory, which is calculated from the final result (IF-FIN). 
In the following figures, relationship between closeness of results to the assigned value and precision 
of the replicate determinations for each laboratory is represented. 
 
The closeness of the mean of the replicate measurements to the assigned value (reference value), on 
the x-axis, is plotted against the precision (the standard deviation for repeatability of each set of 
replicate measurements), on the y-axis, for the four target PAHs. Both axes are in µg/kg units.  
Laboratories are represented by blue dots. 
The assigned value (reference value) is depicted by a vertical solid red line. The light blue area 
indicates the satisfactory performance area defined, for each analyte, by the following criteria. 
Regarding closeness to the assigned value, performance was classified as satisfactory if z  2, which 
means that the acceptable range is defined by the assigned value 2P.  
The limit for satisfactory performance for precision was defined by the average of all within-laboratory 
standard deviations for that analyte (without removing outliers) multiplied by 1,5.  
Benz[a]anthracene (BaA) 
 
Figure 77: Distribution of mean and standard deviation of replicate measurements. The assigned 
value is 2,1 µg/kg 
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Benzo[a]pyrene (BaP) 
 
Figure 78: Distribution of mean and standard deviation of replicate measurements. The assigned 
value is 0,9 µg/kg 
 
59B enzo[b]fluoranthene (BbF) 
 
Figure 79: Distribution of mean and standard deviation of replicate measurements. The assigned 
value is 4,0 µg/kg 
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Chrysene (CHR) 
 
Figure 80: Distribution of mean and standard deviation of replicate measurements. The assigned 
value is 1,3 µg/kg 
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Annex 6: Answers from the questionnaire 
Did you find the instructions distributed for this PT adequate?  
If NO, please describe here the main problems you were confronted with (e.g. registration, reporting) 
 
Lab ID YES/NO If NO, why? 
B028 YES  
B101 YES  
D638 YES  
D252 YES  
F103 YES  
G982 YES  
G410 YES  
H559 NO Method details were lost every time although I saved them before moving on. Our technique is GC-MS/MS. 
H328 YES  
H333 YES  
I021 YES  
K486 YES  
K023 NO Several times experiencing 505 or 500 Server error when trying to save or submit  Questionnaire 
K252 YES  
L218 YES  
L644 YES  
P874 NO 
Order of PAHs in the Tol Soln, formula & Questionnaire all differ!!, confusing 
& highly annoying. Form would keep defaulting to page 1, would not go 
forwards or backwards properly after saving. Having to put in values 1 at a 
time is very slow & risks transcript errors. Could not alter present/ uk/kg  on 
Page 3! My Technique and Faktor were same- should have fill function- Not 
all filled in!..... 
R027 YES  
R867 YES  
S637 YES  
S945   
S181 YES  
T796 YES  
V015 YES  
W640 YES  
W490 YES  
 
Did your laboratory perform PAHs analysis in infant formulae and follow-on formulae before?  
If YES, for how long? 
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If YES, how many samples does your laboratory analyse each year for this food category? 
If YES, is your laboratory accredited for the method applied and the matrix? 
 
Lab ID YES/NO If YES, for how long? 
If YES, how 
many 
samples? 
If YES, is the method 
accredited 
B028 NO    
B101 NO    
D638 YES 5 years A) <10 YES, within a flexible scope accreditation 
D252 
YES validation of method in 
autumn 2009, LOD and 
LOQ above is based on dry 
weight. 
A) <10 YES, within a flexible scope 
accreditation 
F103 NO    
G982 YES 12 -18 months B) 10-50 YES 
G410 NO   YES 
H559 NO    
H328 NO    
H333 NO    
I021 NO   No 
K486 NO    
K023 YES 1 month A) <10 YES, within a flexible scope accreditation 
K252 NO    
L218 YES since 2006 A) <10 YES 
L644 YES since 2008 B) 10-50 NO 
P874 YES >10 years D) >100 YES 
R027 NO    
R867 NO    
S637 NO    
S945     
S181 NO    
T796 YES FOR 24 MONTHS A) <10 YES 
V015 NO    
W640 YES Three years A) <10 YES 
W490 NO    
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How did you prepare the sample?     
Which extraction method did you use?  
Which was the main purification step of your method? 
 
Lab ID Sample preparation Extraction Purification 
B028  Homogenisation  Saponification  Solvent partitioning 
B101  Homogenisation  Other  Size-exclusion chromatography  
D638  Homogenisation  Other  Solid phase extraction  
D252  Addition of sand  Pressurised liquid extraction  Solid phase extraction  
F103  No Preparation  Other  Size-exclusion chromatography  
G982  Homogenisation  Saponification  Solvent partitioning 
G410 Homogenisation plus addition of desiccant  Pressurised liquid extraction  Size-exclusion chromatography  
H559  Homogenisation  Pressurised liquid extraction  Solid phase extraction  
H328  Addition of desiccant  Pressurised liquid extraction  Solid phase extraction  
H333  Homogenisation plus addition of desiccant  Pressurised liquid extraction 
 Donor-acceptor complex 
chromatography  
I021  No Preparation  Saponification  Solid phase extraction  
K486  No Preparation  Saponification  Solid phase extraction  
K023  Homogenisation plus addition of desiccant  Other  Solid phase extraction  
K252  No Preparation  Other  Donor-acceptor complex chromatography  
L218  No Preparation  Saponification  Solid phase extraction  
L644  Homogenisation  Other  Solid phase extraction 
P874  Homogenisation  Saponification  Solvent partitioning 
R027  Addition of desiccant  Other  Solid phase extraction  
R867  Homogenisation plus addition of desiccant  Soxhlet extraction  Size-exclusion chromatography  
S637  Addition of desiccant  Soxhlet extraction  Solid phase extraction  
S945    
S181  No Preparation  Saponification  Solid phase extraction  
T796  No Preparation  Saponification  Solid phase extraction 
V015  No Preparation Pressurised liquid extraction   Solid phase extraction  
W640  No Preparation  Saponification  Solid phase extraction  
W490  Homogenisation  Other  Size-exclusion chromatography  
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Which was the main instrumental-detection method you applied? 
In case you applied a gas-chromatographic technique, please describe the capillary column used 
In case you applied a liquid-chromatographic technique, please describe the analytical column used 
 
Lab ID Detection HPLC Column GC- Column 
B028  HPLC-FLD LiChroCART 250-4  LiChrosper PAH (5 µm)  
B101  HPLC-FLD PAH C18 5um, 4.6 x 250 mm (Waters)  
D638 HPLC-FLD  GC-MS 
RESTEK PINNACLE II PAH 
4um 150 x 4.6mm DB-EUPAH, 20 m×0.18 mm×0.14µm 
D252  GC-MS  DB5-MS 
F103  LC-MS/MS Zorbax Eclipse PAh 2.1x50 mm 1.8 µm  
G982  GC-MS  60m x 0.25mm x 0.25µm 5% phenylpolysiloxane 
G410  HPLC-FLD-UV PAH C18 5um; 4,6x250mm, 5 μm  (Waters P/N 186001265)  
H559  GC-MS/MS  Zebron ZB-50 
H328  GC-MS  35% phenyl - 65%methyl 
H333  HPLC-FLD-UV Varian pursuit 3 PAH 100*4.6 mm  
I021  HPLC-FLD-UV Grace Vydac 201TP54, reverse phase C18,250x4.6mm,5↨0m  
K486  GC-MS  Zebron ZB-50 30m*0.25mm*0.25µm 
K023  GC-MS  DB-EUPAH, 20 m×0.18 mm×0.14µm 
K252  HPLC-FLD Varian Pursuit PAH S/N 250x4.6  
L218  GC-MS  DB-17MS 30m x 0.25mm, 0.25 µm film 
L644  GC-MS  DB-EUPAH 
P874  GC-MS  DB5 
R027  HPLC-FLD-UV Waters PAH C18, S-5um, 250x3.0 um  
R867 HPLC-FLD  GC-MS 
Waters PAH (250mm x 2.1mm 
x 5um) DB-17MS (30m x 0.25mm x 0.25 µm) 
S637  HPLC-FLD VARIAN PAH Pursuit, 250 x 4,6 mm, 5um  
S945    
S181  HPLC-FLD-UV Vydac 201 TP54 4,6*250 mm 5µm  
T796  HPLC-FLD-UV 
VYDAC  REVERSE PHASE 
C18 201TP54  250 X 4.6 mm  
5um 
 
V015  GC-MS/MS  Zebron ZB-50 MS (30m x 0.25 mm x 0.25 µm) 
W640  GC-MS  DB-35, 30 m 
W490  GC-HRMS  Varian Select PAH 
 120
Did you encounter any problems during the analysis of the food sample? 
If YES, please describe shortly  
Did you encounter any problems during the solvent sample analysis? 
If YES, please describe shortly 
 
Lab ID 
Problems 
Food 
YES/NO 
If YES, please describe shortly 
Problems 
solvent 
YES/NO 
If YES, please describe 
shortly 
B028 NO  NO   
B101 NO  NO   
D638 NO  NO   
D252 YES  NO   
F103 NO  NO   
G982 NO  NO   
G410 NO  NO   
H559 YES 
Blank contamination:response peak in a 
blank sample in B(a)P,CHR and B(a)A 
which is possibly due to our sample 
preparation system. I had to make a blank 
reduction to all except BbF results 
because the recoveries for spiked samples 
were too high. I did not have enough time 
to verify and reanalyse the blank 
samples. 
NO   
H328 NO  NO   
H333 NO  NO   
I021 NO  NO   
K486 NO  NO   
K023 NO  NO   
K252 YES 
stability problems; analysis fulfills 
quality criteria but is less stable as we are 
used to. 
YES 
SAME (stability problems; 
analysis fulfills quality criteria 
but is less stable as we are used 
to) 
L218 YES Blank sample and PT-sample seemed to contain 5-MC. NO   
L644 NO  NO   
P874 NO  NO   
R027 NO  NO   
R867 NO  NO   
S637 NO  NO   
S945      
S181 NO  NO   
T796 NO  NO   
V015 NO  NO   
W640 NO  YES Have to change injection temp due to boiling point of toluene 
W490 NO  NO   
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Annex 7: Supporting documents 
Announcement of the PT 
 
From:  LERDA Donata (JRC-GEEL)   On Behalf Of JRC IRMM CRL PAH 
Sent: Tue 13/04/2010 11:44 
To:  
Subject: ARES 188298 :EU-RL PAHs first PT of 2010 
 
Dear Madame / Sir,          JRC 
D08/DL/hn/ARES 188298 (2010)    
 
The European Union Reference Laboratory for PAHs would like to inform you that the 2010 
proficiency test (PT) on PAHs in infant formula will start soon. Dispatch of the samples will take place 
in week 19 or 20 and results are expected to be reported within 4 weeks after dispatch. 
 
You will receive by week 17 the Outline of the study and the link for registration. 
 
As we are going to dispatch PAHs solutions in different solvents, either toluene or acetonitrile 
depending on your needs, please answer to this mail by the 20th of April 2010 indicating your 
preference (TOLUENE or ACETONITRILE). 
 
  
  
Thank you for the co-operation and best regards, 
 
 
Donata 
 
 
 
Donata Lerda 
Food Safety and Quality Unit 
Institute for Reference Materials and Measurements 
(EC – JRC – IRMM)  
Postal address: Retieseweg 111, B-2440 Geel, Belgium 
 
Phone:  +32 14 571 826  
Fax:    +32 14 571 783  
e-mail: donata.lerda@ec.europa.eu 
 
DISCLAIMER: The views expressed are purely those of the writer and may not in any circumstances be regarded as 
stating an official position of the European Commission 
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Announcement registration opening 
 
From:  LERDA Donata (JRC-GEEL)   On Behalf Of JRC IRMM CRL PAH 
Sent: Fri 16/04/2010 16:06 
To:  
Subject: ARES 197277 (2010): Opening of registration for the first EU-RL PAHs 2010 proficiency test 
 
Dear Madame / Sir,           
 
The European Union Reference Laboratory for PAHs would like to inform you that the registration for 
2010 proficiency test (PT) on PAHs will be open from 00:00 of 19/04/2010 to midnight of 
28/04/2010.  
 
The link for registration, reported also in the attached document, is 
https://irmm.jrc.ec.europa.eu/ilc/ilcRegistration.do?selComparison=399 
Please note that the fields marked with a * are mandatory.  
After confirmation you must provide us with a signed and stamped copy of the Registration Form, 
either by FAX or by e-mail as a PDF file (mail address: jrc-irmm-crl-pah@ec.europa.eu) . 
 
Dispatch of the samples, as already announced, will take place in week 19 or 20 and you will receive 
an announcement of dispatch a few days before it will take place. 
Results are expected to be reported within 4 weeks after dispatch. Please note that no extension of the 
deadline will be granted (the interface for reporting will be closed). 
 
You will receive the detailed outline of the study with the PT samples. 
The link for reporting will be sent to you upon dispatch of the PT samples together with the exact 
deadline for reporting. 
 
If you did not yet indicate your preference for the solvent solutions of PAHs (either TOLUENE 
or ACETONITRILE) as asked in the mail of 14/04/2010, please do so as soon as possible (within 
the 28/04/2010 at last), by sending an e-mail to jrc-irmm-crl-pah@ec.europa.eu. 
 
 
ARES 197277 - 
Opening of regis...
 
 Thank you for the co-operation and best regards, 
Donata 
 
Donata Lerda 
Food Safety and Quality Unit 
Institute for Reference Materials and Measurements 
(EC – JRC – IRMM)  
Postal address: Retieseweg 111, B-2440 Geel, Belgium 
Phone:  +32 14 571 826  
Fax:    +32 14 571 783  
e-mail: donata.lerda@ec.europa.eu 
 
DISCLAIMER: The views expressed are purely those of the writer and may not in any circumstances be regarded as 
stating an official position of the European Commission 
Attached PDF(ARES 197277 - Opening of registration letter PT infant formula 2010.pdf) 
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Reminder for registration  
 
From:  LERDA Donata (JRC-GEEL)   On Behalf Of JRC IRMM CRL PAH 
Sent: Mon 26/04/2010 09:39 
To:  
Subject: Reminder: ARES 197277 (2010): Opening of registration for the first EU-RL PAHs 2010 proficiency test 
 
Dear Madame / Sir,           
 
This mail is to be intended as a reminder for the registration to the forthcoming 2010 proficiency test 
(PT) on PAHs. 
 
 The registration will close at midnight of 28/04/2010. For the NRLs the participation is 
mandatory. Please do register if you did not yet. 
 Some of the participants did not yet send us their preference for the solvent (either toluene or 
acetonitrile) they would like to have for the solutions included in the PT. Please do it by midnight 
of the 28/04/2010. In case you would not indicate any preference you will receive both solutions 
and you will be required to report the results for both. 
 
 
Best regards, 
 
 
Donata 
 
 
 
Donata Lerda 
Food Safety and Quality Unit 
Institute for Reference Materials and Measurements 
(EC – JRC – IRMM)  
Postal address: Retieseweg 111, B-2440 Geel, Belgium 
 
Phone:  +32 14 571 826  
Fax:    +32 14 571 783  
e-mail: donata.lerda@ec.europa.eu 
 
DISCLAIMER: The views expressed are purely those of the writer and may not in any circumstances be regarded as 
stating an official position of the European Commission 
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From:  LERDA Donata (JRC-GEEL)   On Behalf Of JRC IRMM CRL PAH 
Sent: Mon 26/04/2010 11:39 
To:  
Subject: Reminder: ARES 197277 (2010): Opening of registration for the first EU-RL PAHs 2010 proficiency test 
 
Dear Madame / Sir, 
 
Please note that a signed and stamped copy should be sent to the EU-RL to confirm your registration. 
Otherwise your laboratory will not be considered as registered. 
 
Best regards, 
 
 
Donata           
 
 
Donata Lerda 
Food Safety and Quality Unit 
Institute for Reference Materials and Measurements 
(EC – JRC – IRMM)  
Postal address: Retieseweg 111, B-2440 Geel, Belgium 
 
Phone:  +32 14 571 826  
Fax:    +32 14 571 783  
e-mail: donata.lerda@ec.europa.eu 
 
DISCLAIMER: The views expressed are purely those of the writer and may not in any circumstances be regarded as 
stating an official position of the European Commission 
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76BAnnouncement of material dispatch 
From:  LERDA Donata (JRC-GEEL)    
Sent: Wed 05/05/2010 16:38 
To:  
Subject:  
 
 
EUROPEAN COMMISSION 
JOINT RESEARCH CENTRE 
 
Institute for reference materials and measurements  
European Reference Laboratory for  
Polycyclic Aromatic Hydrocarbons (PAH)  
Geel, 06 May 2010 
EU-RL PAHs/DLE (2010) 
 
 
 
Shipment of materials for the EU-RL PT-2010 on PAHs in infant formula 
 
 
Contact person  
Institute 
Address 
 
NRL 
 
Dear Contact person, 
 
We are planning to dispatch the materials for the next proficiency test on 10th of May 2010 via DHL.  
Please be prepared to receive the samples and to store them in an appropriate way (room temperature 
for the infant formula samples and cool, 4ºC, and dark for the solutions). 
 
We will inform you about the details of the shipment, the analyses to be made, and deadline for 
reporting as soon as the items will have left our premises. 
 
 
With best regards, 
 
 
Donata Lerda 
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77BDHL shipment notification 
From:  LERDA Donata (JRC-GEEL)   On Behalf Of JRC IRMM CRL PAH 
Sent: Tue 11/05/2010 08:55 
To:  
Subject: FW: DHL Intraship - Shipment notification 
 
Dear Contact person, 
 
Please find herein below the link for tracking the PT parcel. 
Best regards, 
 
Donata  
 
Donata Lerda 
Food Safety and Quality Unit 
Institute for Reference Materials and Measurements 
(EC – JRC – IRMM)  
Postal address: Retieseweg 111, B-2440 Geel, Belgium 
 
Phone:  +32 14 571 826  
Fax:    +32 14 571 783  
e-mail: donata.lerda@ec.europa.eu 
 
DISCLAIMER: The views expressed are purely those of the writer and may not in any 
circumstances be regarded as stating an official position of the European Commission 
 
-----Original Message----- 
From: pascal.vergucht@ec.europa.eu [mailto:pascal.vergucht@ec.europa.eu]  
Sent: Monday, May 10, 2010 3:07 PM 
To: SZILAGYI Szilard (JRC-GEEL); LERDA Donata (JRC-GEEL) 
Subject: DHL Intraship - Shipment notification 
 
DHL EXPRESS 
SHIPMENT ADVISORY 
 
Subject:PT IF 2010 
 
The following piece has been sent by Pascal Vergucht from 
IRMM via DHL Express on 10.05.2010 (AWB# 4960429320). 
If you wish to track this shipment please contact your local 
DHL Customer Service office or visit the DHL website at 
http://www.dhl.be/ 
 
If you have a web-enabled mail reader, click the link below to view 
shipment tracking details: http://www.dhl.com/cgi-bin/tracking.pl? 
or just forward this Email to tracknl@dhl.com and you will receive feedback. 
 
SEND TO: Institute 
FAO    : Contact person- Address 
 
SENDER : IRMM 
From   : Pascal Vergucht 
Retieseweg 111 
Geel – 2440 (Belgium) 
 
SHIPMENT CONTENTS: 
Scientific samples 
 
SHIPPER REFERENCE: .. 
AWB:      4960429320 
WEIGHT:   0.7 
PIECES:   1 
CONTENTS: Scientific samples 
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78BReporting Instructions 
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Standard solution (CAL): specification sheet 
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Solution in acetonitrile of PAHs, known content: specification sheet 
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Solution in toluene of PAHs, known content: specification sheet 
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Sample receipt confirmation form 
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EUR 24673 EN – Joint Research Centre – Institute for Reference Materials and Measurements 
Title: Report on the 6th inter-laboratory comparison test organised by the European Union Reference Laboratory 
for Polycyclic Aromatic Hydrocarbons – 15+1 EU priority PAHs in infant formula and solvent solutions 
Authors: Donata Lerda, Patricia Lopez Sanchez, Szilard Szilagyi, Thomas Wenzl 
Luxembourg: Publications Office of the European Union 
2010 – 145 pp. – 21.0 x 29.7 cm 
EUR – Scientific and Technical Research series – ISSN 1018-5593 
ISBN 978-92-79-18972-2 
doi:10.2787/35680 
 
 
Abstract 
The European Union Reference Laboratory for PAHs (EU-RL-PAHs), operated by the Institute for Reference 
Materials and Measurements (IRMM) of the Joint Research Centre (JRC), organises yearly one or more proficiency 
tests (PTs) within the scope of the Regulation (EC) 882/2004. 
 
The proficiency test here reported concerned the determination of the 15+1 EU priority polycyclic aromatic 
hydrocarbons (PAHs) in an infant formula test sample. Participants to these PT were National Reference 
Laboratories for PAHs (NRLs-PAHs). The number of participants was 25. They were requested to report for the 
future four target PAHs  (benz[a]anthracene, benzo[b]fluoranthene, benzo[a]pyrene, and chrysene) quantitative 
results, and absence or presence of the other 12 PAHs. 
 
The PT was organised along the lines of the IUP AC Harmonised Protocol for the Proficiency Testing of  
Analytical Chemistry Laboratories. 
 
The test material used was dry infant formula spiked with a 15+1 EU priority PAHs and a solution of the target 
analytes in, depending of the preference of the particular laboratory, either acetonitrile or toluene. 
 
The results for the four t arget PAHs were rated with z-scores and zeta-scores. About 88 % of the reported 
results were attributed with z-scores with an absolute value of below two, which is the threshold for satisfactory 
performance. The proportion of satisfactory zeta-scores was smaller, which was caused by potentially too 
optimistic measurement uncertainty estimates. 
 
 
 
 
How to obtain EU publications 
 
Our priced publications are available from EU Bookshop (http://bookshop.europa.eu), where you can place 
an order with the sales agent of your choice. 
 
The Publications Office has a worldwide network of sales agents. You can obtain their contact details by 
sending a fax to (352) 29 29-42758. 
 
 
The mission of the JRC is to provide customer-driven scientific and technical support 
for the conception, development, implementation and monitoring of EU policies. As a 
service of the European Commission, the JRC functions as a reference centre of 
science and technology for the Union. Close to the policy-making process, it serves 
the common interest of the Member States, while being independent of special 
interests, whether private or national. 
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